Pre-earnings options volume in Ocean Biomedical Inc is normal with calls leading puts 13:1. Implied volatility suggests the market is anticipating a move near 14.5%, or 61c, after results are released. Median move over the past eight quarters is 6.0%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OCEA:
- Largest borrow rate increases among liquid names
- Ocean Biomedical Inc options imply 31.8% move in share price post-earnings
- Ocean Biomedical announces Virion to present study of VRON-0200
- Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting